1-4 of 4
Paul Williamson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Deferasirox (Exjade ® ) with up to 4.5 Years of Treatment in Patients with Thalassemia Major: A Pooled Analysis

Maria Domenica Cappellini, Renzo Galanello, Antonio Piga, Alan Cohen, Antonis Kattamis, Yesim Aydinok, Paul Williamson, Lisa Rojkjaer, John B Porter
Journal: Blood
Blood (2008) 112 (11): 5411.
https://doi.org/10.1182/blood.V112.11.5411.5411
Published: 2008
Journal Articles

Long-Term Treatment with Deferasirox (Exjade®, ICL670), a Once-Daily Oral Iron Chelator, Is Effective in Patients with Transfusion-Dependent Anemias.

Maria Domenica Cappellini, Elliott Vichinsky, Renzo Galanello, Antonio Piga, Paul Williamson, John B. Porter
Journal: Blood
Blood (2007) 110 (11): 2777.
https://doi.org/10.1182/blood.V110.11.2777.2777
Published: 2007
Journal Articles

Pre-Transplant Biomarkers Predict GVHD and Treatment-Related Mortality in Patients Treated with Extracorporeal Photopheresis Prior to Allogeneic Bone Marrow Transplantation.

Peter J. O’Brien, PhD, Brian Bolwell, MD, Sunil Abhyankar, MD, Paul Shaughnessy, MD, Koen van Besien, MD, Paul Williamson, MD, Kim A. Campbell, PhD
Journal: Blood
Blood (2006) 108 (11): 5182.
https://doi.org/10.1182/blood.V108.11.5182.5182
Published: 2006
Journal Articles

A Randomized Single−Blind Study of Extracorporeal Photopheresis with UVADEX® Plus Conventional Therapy (CT) Compared to CT Alone in Chronic GVHD.

Mary E.D. Flowers, MD, Koen Van Besien, MD, Jane Apperley, MD, Andrea Bacigalupo, MD, Ahmet Elmaagacli, MD, Andrew Grigg, MD, Hans-Jochem Kolb, MD, Luis Fernando Bouzas, MD, Mauricette Michallet, MD, Vijay Reddy, MD, Jim Wang, MD, Paul Williamson, MD, Robert Knobler, MD, Hildegard Greinix, MD
Journal: Blood
Blood (2006) 108 (11): 758.
https://doi.org/10.1182/blood.V108.11.758.758
Published: 2006